Literature DB >> 22700402

High-resolution in vivo imaging of fluorescent proteins using window chamber models.

Gregory M Palmer1, Andrew N Fontanella, Siqing Shan, Mark W Dewhirst.   

Abstract

Fluorescent proteins enable in vivo characterization of a wide and growing array of morphological and functional biomarkers. To fully capitalize on the spatial and temporal information afforded by these reporter proteins, a method for imaging these proteins at high resolution longitudinally is required. This chapter describes the use of window chamber models as a means of imaging fluorescent proteins and other optical parameters. Such models essentially involve surgically implanting a window through which tumor or normal tissue can be imaged using existing microscopy techniques. This enables acquisition of high-quality images down to the cellular or subcellular scale, exploiting the diverse array of optical contrast mechanisms, while also maintaining the native microenvironment of the tissue of interest. This makes these techniques applicable to a wide array of problems in the biomedical sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700402      PMCID: PMC3736593          DOI: 10.1007/978-1-61779-797-2_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  A novel rodent mammary window of orthotopic breast cancer for intravital microscopy.

Authors:  Siqing Shan; Brian Sorg; Mark W Dewhirst
Journal:  Microvasc Res       Date:  2003-03       Impact factor: 3.514

2.  Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation.

Authors:  Y Tsuzuki; C Mouta Carreira; M Bockhorn; L Xu; R K Jain; D Fukumura
Journal:  Lab Invest       Date:  2001-10       Impact factor: 5.662

3.  Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.

Authors:  L Chatzistamou; A V Schally; A Nagy; P Armatis; K Szepeshazi; G Halmos
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

4.  Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines.

Authors:  H Nakagawa; K Tsuta; K Kiuchi; H Senzaki; K Tanaka; K Hioki; A Tsubura
Journal:  Carcinogenesis       Date:  2001-06       Impact factor: 4.944

5.  Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents.

Authors:  R Brandt; A M Wong; N E Hynes
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

6.  The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.

Authors:  S Shan; A C Lockhart; W Y Saito; A M Knapp; K R Laderoute; M W Dewhirst
Journal:  Clin Cancer Res       Date:  2001-08       Impact factor: 12.531

Review 7.  Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma.

Authors:  T Yoneda; T Michigami; B Yi; P J Williams; M Niewolna; T Hiraga
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

Review 8.  The seed and soil hypothesis: vascularisation and brain metastases.

Authors:  Isaiah J Fidler; Seiji Yano; Ruo-Dan Zhang; Takahashi Fujimaki; Corazon D Bucana
Journal:  Lancet Oncol       Date:  2002-01       Impact factor: 41.316

9.  Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53.

Authors:  S Lebedeva; S Bagdasarova; T Tyler; X Mu; D R Wilson; R A Gjerset
Journal:  Hum Gene Ther       Date:  2001-05-01       Impact factor: 5.695

10.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.

Authors:  M Skobe; T Hawighorst; D G Jackson; R Prevo; L Janes; P Velasco; L Riccardi; K Alitalo; K Claffey; M Detmar
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

View more
  9 in total

1.  Luminescent difluoroboron β-diketonate PEG-PLA oxygen nanosensors for tumor imaging.

Authors:  Jelena Samonina-Kosicka; Douglas H Weitzel; Christina L Hofmann; Hansford Hendargo; Gabi Hanna; Mark W Dewhirst; Gregory M Palmer; Cassandra L Fraser
Journal:  Macromol Rapid Commun       Date:  2015-03-09       Impact factor: 5.734

2.  Effects of high-dose microbeam irradiation on tumor microvascular function and angiogenesis.

Authors:  Andrew N Fontanella; Mary-Keara Boss; Michael Hadsell; Jian Zhang; Thies Schroeder; Katherine G Berman; Mark W Dewhirst; Sha Chang; Gregory M Palmer
Journal:  Radiat Res       Date:  2015-01-09       Impact factor: 2.841

3.  Quantifying the effects of anesthesia on intracellular oxygen via low-cost portable microscopy using dual-emissive nanoparticles.

Authors:  Ashlyn G Rickard; Meng Zhuang; Christopher A DeRosa; Mark W Dewhirst; Cassandra L Fraser; Gregory M Palmer
Journal:  Biomed Opt Express       Date:  2022-06-09       Impact factor: 3.562

4.  Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.

Authors:  Theresa Falls; Dominic Guy Roy; John Cameron Bell; Marie-Claude Bourgeois-Daigneault
Journal:  ILAR J       Date:  2016

5.  Optimization of the dorsal skinfold window chamber model and multi-parametric characterization of tumor-associated vasculature.

Authors:  Azusa Maeda; Ralph S DaCosta
Journal:  Intravital       Date:  2014-02-04

6.  Imaging windows for long-term intravital imaging: General overview and technical insights.

Authors:  Maria Alieva; Laila Ritsma; Randy J Giedt; Ralph Weissleder; Jacco van Rheenen
Journal:  Intravital       Date:  2014-08-11

7.  In Vivo Optical Metabolic Imaging of Long-Chain Fatty Acid Uptake in Orthotopic Models of Triple-Negative Breast Cancer.

Authors:  Megan C Madonna; Joy E Duer; Joyce V Lee; Jeremy Williams; Baris Avsaroglu; Caigang Zhu; Riley Deutsch; Roujia Wang; Brian T Crouch; Matthew D Hirschey; Andrei Goga; Nirmala Ramanujam
Journal:  Cancers (Basel)       Date:  2021-01-05       Impact factor: 6.639

8.  In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence.

Authors:  Megan C Madonna; Joy E Duer; Brock J McKinney; Enakshi D Sunassee; Brian T Crouch; Olga Ilkayeva; Matthew D Hirschey; James V Alvarez; Nirmala Ramanujam
Journal:  NPJ Breast Cancer       Date:  2022-09-26

9.  Clinical development of new drug-radiotherapy combinations.

Authors:  Ricky A Sharma; Ruth Plummer; Julie K Stock; Tessa A Greenhalgh; Ozlem Ataman; Stephen Kelly; Robert Clay; Richard A Adams; Richard D Baird; Lucinda Billingham; Sarah R Brown; Sean Buckland; Helen Bulbeck; Anthony J Chalmers; Glen Clack; Aaron N Cranston; Lars Damstrup; Roberta Ferraldeschi; Martin D Forster; Julian Golec; Russell M Hagan; Emma Hall; Axel-R Hanauske; Kevin J Harrington; Tom Haswell; Maria A Hawkins; Tim Illidge; Hazel Jones; Andrew S Kennedy; Fiona McDonald; Thorsten Melcher; James P B O'Connor; John R Pollard; Mark P Saunders; David Sebag-Montefiore; Melanie Smitt; John Staffurth; Ian J Stratford; Stephen R Wedge
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.